Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristian B Filion

Showing results (191-200 of 304) with videos related to

Pageof 31
Sort By:
American Journal of Epidemiology|November 3, 2022
Breaking Research Silos and Stimulating "Innovation at the Edges" in EpidemiologyShahar Shmuel, Charles E Leonard, Katsiaryna Bykov, et al.
Pharmacoepidemiology and Drug Safety|January 6, 2026
Emulating a Randomized Controlled Trial of Long-Acting Insulins and Cardiovascular Events Using Real-World Data for Patients With Type 2 DiabetesWanning Wang, Pauline Reynier, Michael Webster-Clark, et al.
Diabetes, Obesity & Metabolism|November 10, 2025
Sodium glucose co-transporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors and the risk of ventricular arrhythmia among patients with type 2 diabetes: A population-based cohort studyWang-Choi Tang, Pauline Reynier, Antonios Douros, et al.
Heart Rhythm|July 2, 2014
Prognostic value of atrial fibrillation inducibility after right atrial flutter ablationJacqueline Joza, Kristian B Filion, Maria Eberg, et al.
Pharmacoepidemiology and Drug Safety|October 6, 2018
Identification of incident pancreatic cancer in Ontario administrative health data: A validation studyJennifer W Wu, Laurent Azoulay, Anjie Huang, et al.
The American Journal of Medicine|February 1, 2025
Mechanisms of GLP-1 Receptor Agonist-Induced Weight Loss: A Review of Central and Peripheral Pathways in Appetite and Energy RegulationAreesha Moiz, Kristian B Filion, Michael A Tsoukas, et al.
World Journal of Urology|September 10, 2020
Trends in the pharmacological treatment of benign prostatic hyperplasia in the UK from 1998 to 2016: a population-based cohort studyHenok Tadesse Ayele, Pauline Reynier, Laurent Azoulay, et al.
Diabetes Care|August 29, 2018
Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Incident Diabetic RetinopathyAntonios Douros, Kristian B Filion, Hui Yin, et al.
The American Journal of Cardiology|November 6, 2016
Effect of Fixed-Bolus (5,000 Units) Unfractionated Heparin Before Primary Percutaneous Coronary Intervention on Activated Clotting Time, Time Flow, and All-Cause MortalitySalvatore Mottillo, Kristian B Filion, Lawrence Joseph, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 28, 2020
Association Between Nonsteroidal Antiinflammatory Drug Use and Adverse Clinical Outcomes Among Adults Hospitalized With Coronavirus 2019 in South Korea: A Nationwide StudyHan Eol Jeong, Hyesung Lee, Hyun Joon Shin, et al.
Pageof 31

Showing results (191-200 of 304) with videos related to

Sort By:
Pageof 31
American Journal of Epidemiology|November 3, 2022
Breaking Research Silos and Stimulating "Innovation at the Edges" in EpidemiologyShahar Shmuel, Charles E Leonard, Katsiaryna Bykov, et al.
Pharmacoepidemiology and Drug Safety|January 6, 2026
Emulating a Randomized Controlled Trial of Long-Acting Insulins and Cardiovascular Events Using Real-World Data for Patients With Type 2 DiabetesWanning Wang, Pauline Reynier, Michael Webster-Clark, et al.
Diabetes, Obesity & Metabolism|November 10, 2025
Sodium glucose co-transporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors and the risk of ventricular arrhythmia among patients with type 2 diabetes: A population-based cohort studyWang-Choi Tang, Pauline Reynier, Antonios Douros, et al.
Heart Rhythm|July 2, 2014
Prognostic value of atrial fibrillation inducibility after right atrial flutter ablationJacqueline Joza, Kristian B Filion, Maria Eberg, et al.
Pharmacoepidemiology and Drug Safety|October 6, 2018
Identification of incident pancreatic cancer in Ontario administrative health data: A validation studyJennifer W Wu, Laurent Azoulay, Anjie Huang, et al.
The American Journal of Medicine|February 1, 2025
Mechanisms of GLP-1 Receptor Agonist-Induced Weight Loss: A Review of Central and Peripheral Pathways in Appetite and Energy RegulationAreesha Moiz, Kristian B Filion, Michael A Tsoukas, et al.
World Journal of Urology|September 10, 2020
Trends in the pharmacological treatment of benign prostatic hyperplasia in the UK from 1998 to 2016: a population-based cohort studyHenok Tadesse Ayele, Pauline Reynier, Laurent Azoulay, et al.
Diabetes Care|August 29, 2018
Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Incident Diabetic RetinopathyAntonios Douros, Kristian B Filion, Hui Yin, et al.
The American Journal of Cardiology|November 6, 2016
Effect of Fixed-Bolus (5,000 Units) Unfractionated Heparin Before Primary Percutaneous Coronary Intervention on Activated Clotting Time, Time Flow, and All-Cause MortalitySalvatore Mottillo, Kristian B Filion, Lawrence Joseph, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 28, 2020
Association Between Nonsteroidal Antiinflammatory Drug Use and Adverse Clinical Outcomes Among Adults Hospitalized With Coronavirus 2019 in South Korea: A Nationwide StudyHan Eol Jeong, Hyesung Lee, Hyun Joon Shin, et al.
Pageof 31